Diana Karpman

Terminal Complement Inhibitor Eculizumab in Atypical Hemolytic–Uremic Syndrome

Christophe Legendre, Christoph Licht, Petra Muus et al. · New England Journal of Medicine · 2013 · 1.6K citations · Full text

Medicine, Hematology, Pharmacotherapy +17

Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference

Timothy H.J. Goodship, H. Terence Cook, Fádi Fakhouri et al. · Kidney International · 2016 · 695 citations · Full text

Medicine, Nephrology, Pathology +17

Interleukin 8 Receptor Deficiency Confers Susceptibility to Acute Experimental Pyelonephritis and May Have a Human Counterpart

Björn Frendéus, Gabriela Godaly, Long Hang et al. · The Journal of Experimental Medicine · 2000 · 197 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Complement activation on platelet-leukocyte complexes and microparticles in enterohemorrhagic Escherichia coli–induced hemolytic uremic syndrome

Anne-lie Ståhl, Lisa Sartz, Diana Karpman · Blood · 2011 · 196 citations · Full text

Life Sciences, Immunology, Microbiology +17

Apoptosis of Renal Cortical Cells in the Hemolytic-Uremic Syndrome: In Vivo and In Vitro Studies

Diana Karpman, Anders Håkansson, Maria-Thereza R. Perez et al. · Infection and Immunity · 1998 · 193 citations · Full text

Medicine, Microbiology, Nephrology +15